ArticleFrontiers in immunology2025
Research trends and hotspots in the tumor microenvironment of ovarian cancer: a bibliometrics and visualization study from 2005 to 2024.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The tumor microenvironment (TME) is crucial in influencing the progression and therapeutic response of ovarian cancer. Method: This study conducted a comprehensive bibliometric and visualization analysis of research trends and focal areas concerning the ovarian cancer microenvironment from 2005 to 2024. A total of 1,720 pertinent articles were identified from the Web of Science Core Collection (WoSCC) database. Results: The analysis revealed a notable increase in research activity on the TME of ovarian cancer, particularly during the period from 2019 to 2022. The United States and China were the most active countries in this field, and the University of Texas System was the scientific research institution with the largest number of articles. Conclusion: This study provides a valuable reference for the evolution and prospective directions of TME research in ovarian cancer, underscoring the critical importance of a comprehensive understanding of the TME to enhance treatment strategies for ovarian cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.